TrialThe oncologist2014

A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancer.

Andrew D Seidman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.